IPN, Delhi, India. Open 10-6pm

+91 9891296838 / 9811747774

dulaglutide injection

dulaglutide injection
for subcutaneous use Initial U.S. Approval: 2014

Facts about dulaglutide injection

Approval Date: 2014
Proprietary Name: On Request
Active Ingredient(s): dulaglutide
Dosage Forms And Strengths: Injection: 0.75 mg/0.5 mL solution in a single-dose pen
Injection: 1.5 mg/0.5 mL solution in a single-dose pen
Injection: 0.75 mg/0.5 mL solution in a single-dose prefilled syringe
Injection: 1.5 mg/0.5 mL solution in a single-dose prefilled syringe
Company: Eli Lilly
Diseases: Type 2 diabetes, cardiovascular risk reduction
Medicine Approved By: –
European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
Summary of FDA approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication.  Our professional will provide you with a step-by-step guide on how to legally and safely import “dulaglutide injection” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.

Contact Info

CORPORATE OFFICE:
Basement-B-5-A, Ajit Singh House Building No.12, Yusuf Sarai, South Delhi,
New Delhi:110016 India.

MOBILE / PHONE NUMBER:
M: +91 9811747774, 9891296838.
P / F: +91-11-26532129 / 26536398

EMAIL ID:
info@indianpharmanetwork.co.in

FAX NUMBER:
+91-11-26532129

Query For dulaglutide injection

Approved accessible "dulaglutide injection"

Dulaglutide injection is used as an add-on therapy to diet and exercise to decrease blood glucose levels in adults with type 2 diabetes mellitus.

Trulicity is a medicine used in adults and children from 10 years of age with type 2 diabetes. It is used in addition to appropriate diet and exercise. Trulicity is used: - on its own when use of metformin (another medicine for type 2 diabetes) is not recommended; - as an ‘add-on’ to other diabetes medicines. Trulicity contains the active substance dulaglutide.

How can 1 go about obtaining dulaglutide injection?

If dulaglutide injection are not yet approved or available in your area, you may request its price in India under a specific brand name through IPN. For assistance and guidance, you can contact us by providing complete details. Our pharmaceutical expert will help you find a suitable and practical solution to your query. To receive comprehensive support, please call us at +91 9891 296 838 (Mr. Tarun) / +91 9811 747 774 (Mr. Neeraj).

TRULICITY (dulaglutide) injection, for subcutaneous use Initial U.S. Approval: 2014

References

Indian Pharma Network (IPN), New Delhi. India

Indian Pharma Network (IPN) is registered organisation in India, having highly qualified healthcare professionals of pharmaceutical Industry. Specialized in Oncology Products. Helped more than 6,000 patients. Registration Number : 07AAFFI2544E1ZO under GST Act.
Branch Offices in India : New Delhi | Bengaluru | Kolkata | Lucknow | Jaipur | Jodhpur.
Our Overseas Network UK | Russia | Brazil | Mexico | Germany | France| Italy | Spain | Japan | China| Australia | Brazil | Saudi Arabia | South Africa

Indian Pharma Network
60/4 1st Floor, T&T Building, Indian Oil Complex, Yusuf Sarai, Delhi 110016

Mobile / WhatsApp / Phone
M: +91 9811747774, 9891296838.
P: +91-11-26532129 / 26536398